Cargando…
VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer
VPS33B is reported to be a tumor suppressor in hepatocellular carcinoma, nasopharyngeal carcinoma, colon cancer, and lung adenocarcinoma. Here, we observed that reduced VPS33B protein level was an unfavorable factor that promoted the pathogenesis of non-small cell lung cancer (NSCLC) in clinical spe...
Autores principales: | Liu, Jiahao, Wen, Yinghao, Liu, Zhen, Liu, Shu, Xu, Ping, Xu, Yan, Deng, Shuting, Hu, Shulu, Luo, Rongcheng, Jiang, Jingwen, Yu, Guifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779536/ https://www.ncbi.nlm.nih.gov/pubmed/33425490 http://dx.doi.org/10.1016/j.omtn.2020.11.010 |
Ejemplares similares
-
VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma
por: Liang, Zixi, et al.
Publicado: (2019) -
p53 activates miR-192-5p to mediate vancomycin induced AKI
por: Chen, Jinwen, et al.
Publicado: (2016) -
VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin
por: Liu, Zhen, et al.
Publicado: (2020) -
Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision
por: Sun, Cheng-Yuan, et al.
Publicado: (2019) -
Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1
por: Fang, Ling, et al.
Publicado: (2018)